sYNoPsis In two groups of patients undergoing extracorporeal circulation with hypothermia, changes were found in the coagulation mechanism which were probably due to the dosage of polybrene administered.
There are many factors concerned in the production of a bleeding diathesis following extracorporeal circulation with hypothermia. Two major factors are unneutralized heparin and the utilization of clotting factors and platelets induced by hypercoagulability of the blood during cardiac by-pass; fibrinolysis or the development of a circulating anticoagulant are occasional complications. Multiple minor coagulation defects may play their role in the potentiation of the post-operative bleeding. However, in many patients there appears to be no statistical correlation between coagulation studies and bleeding after perfusion; the bleeding as judged by thoracotomy drainage is excessive, but not clinically alarming, and stops spontaneously after 12 to 24 hours. In these cases capillary function may be deficient.
In a series of 12 patients undergoing open-heart surgery, the coagulation mechanism was investigated with special reference to the role of polybrene and heparin in the production of thrombocytopenia and coagulation defects.
It appears likely, as demonstrated by Perkins, Harkins, Gerbode, Rolfs, and Acra (1961) in dogs, that excess polybrene may produce a slight coagulation defect and also that heparin may produce a capillary defect.
METHODS
Twelve patients were investigated who had congenital or acquired heart disease and were undergoing open-heart surgery under superficial or profound hypothermia induced by the Drew technique.
All patients received 90 mg. of heparin for every square metre of surface area. In addition, 25 mg. heparin and 1 g. calcium gluconate were added to each 420 ml. of donor blood which had been collected into 120 ml. of acidcitrate dextrose. Soon after collection, the blood was transported direct to the hospital so that it underwent Received for publication 30 January 1963 only one period of disturbance and refrigeration before use. The blood perfused during operation was either 24 hours old or a combination of 24 and 48 hours old. All the blood given in cases 6 and 11 was 48 hours old. Perfusion resulted in a 50 % to 75 % exchange of patient's blood by donors'. Any blood obtained by suction at the operation site was discarded.
In the first six cases (referred to as group A in the accompanying table), 2-0 mg. polybrene was given for each milligram of heparin used; in the remaining six cases (group B) 15 mg. polybrene was administered for each milligram of heparin.
Patients were investigated usually during the week preceding operation and each was found to have normal platelet levels, platelet adhesiveness, bleeding time (Duke), clotting time (Leeand White), prothrombin time, thromboplastin generation test, fibrinogen, calcium, urea, and electrolyte levels. Post-operative samples were taken two to four hours after polybrene had been administered.
Plasma platelet counts determined in the Coulter electronic cell counter were adjusted to whole blood levels in relation to the packed cell volume.
Platelet adhesiveness was measured by the method of Hellem (1960) . Briefly, the method is as follows: citrated blood is filtered under standard conditions through a glass bead column. The difference in the number of platelets before and after filtration is expressed as a percentage of the total platelet count.
A euglobulin lysis time (von Kaulla and Schultz, 1958 ) was used as a measure of fibrinolysis.
Prothrombin time was determined by the Quick onestage method and partial thromboplastin time by the method of Rodman, Barrow, and Graham (1958) .
A thrombin clotting time (Rothnie and Kinmonth, 1960) sample was taken 10 minutes after the infusion of polybrene was completed.
The total thoracotomy drainage in the first 24 hours was expressed in ml./kg. of body weight.
RESULTS
Differences between the two groups were found in platelet levels, prothrombin time, and partial throm- The excessive drainage in case 6 may be attributed to the development of pulmonary oedema, but there seems to be no contributory factor in case 12. There appeared to be no correlation between the coagulation studies or duration of heparinization and thoracotomy drainage.
DISCUSSION
The activation of coagulation during perfusion, with consequent utilization of clotting factors and platelets, is consistent with the finding of normal or excessively complete prothrombin consumption immediately after perfusion with a decrease a few hours later (Brown and Smith, 1958) . Gans, Siegal, Lillehei, and Krivit (1962) have demonstrated the development of hypercoagulability of either heparinized or acidcitrate dextrose blood (but not plasma) a few hours old circulated through a heart-lung machine alone; the breakdown of platelets and red cells was the factor responsible for the generation of a considerable quantity of thromboplastin. The hypercoagulability was kept in check by heparin or citrate, and was directly related to the duration of perfusion.
Comparable with the effect of perfusion is the simple transfusion of bank blood. the magnitude of the effect. after considering dilution, being related to the number of bottles transfused rather than to the age of the blood (Mustard, 1957; Krevans and Jackson, 1955; Stefanini, 1962) .
Besides the concept of utilization of clotting factors induced by hypercoagulability, a contributory factor in the production of a bleeding diathesis may be the effect of heparin and polybrene on capillaries as well as on the coagulation mechanism.
Polybrene (hexadimethrine bromide) is a polymeric quaternary ammonium salt which acts like protamine and toluidine blue by neutralizing the electric charge of heparin. In vitro, polybrene in concentration comparable to that used clinically interferes with thromboplastic activity; the degree of inhibition varies indirectly with the platelet count (Shanberge, Regan, Talarico, and Busiek, 1961) . Individual variation in the degree of inhibition occurs with polybrene as it does with heparin. Platelet clumping is produced by polybrene in vitro (personal observation). In dogs Perkins et al. (1961) found that 3 to 5 mg. polybrene/kg. of body weight produced a transient lengthening of the whole blood clotting time and reduction ofplatelet levels. After one hour, factors V and VIII are still reduced and prothrombin consumption and cephalin time are still abnormal. Kimura et al. (1959) has shown that larger doses produce prolonged reduction of platelet levels and disruption of mast cells with liberation of histamine, serotonin, heparin, and hyaluronic acid. Renal damage is a further complication.
Heparin similarly produces a transient reduction in platelet levels, probably due to sequestration. Large doses of heparin in rats, in which the thoracic duct had been cannulated, after a latent period of a few hours, produced an increased number of red cells in the lymph (Yoshimura and Djerassi, 1962) . This effect persisted after coagulation and platelet levels had returned to normal and was not decreased by the administration of protamine. This effect was probably due to a direct interaction of heparin with the endothelial lining (Engelberg, 1962) . It is possible that polybrene would have a similar effect.
Although the present study is small for statistical analysis, the results are compatible with the view that excess polybrene may produce a slight coagulation defect and that heparin may produce a capillary defect. There was a slight reduction in activity of the prothrombin complexes as judged by the one-stage prothrombin time, prolonged cephalin time, and reduced platelet levels. These changes were greater in the patients receiving the larger polybrene dosage. The laboratory evidence of a slight coagulation defect was not associated with a haemorrhagic diathesis as assessed by thoracotomy drainage. The drainage in both groups A and B was similar and caused no particular anxiety.
This mild and transient coagulation defect appears to be of little clinical significance. While it is probably important to neutralize all traces of heparin, it is wise not to exceed the dose of polybrene unless there is evidence of unneutralized heparin. The use of the thrombin clotting time test overestimates the requirements of polybrene since platelet-poor plasma is used and platelets have an anti-heparin activity. Also the anticoagulant activity of polybrene is increased in thrombocytopenic blood.
Many published cases show lack of correlation between coagulation studies and bleeding after perfusion, but the possible role of polybrene as a contributory factor is overlooked; also, heparin and polybrene should be considered, together with anoxia, acidosis, blood sludging, hypothermia, and poor tissue perfusion, as causes of capillary damage resulting in post-operative bleeding.
ADDENDUM
Since this paper was submitted for publication, polybrene has been discontinued because of the renal toxic effect and difficulty in providing a preparation of standard average molecular weight. Moreover, Stern and Rinker (1963) 
